Nureca’s Rs 100 crore public issue, which was open for subscription between February 15 and 18, 2021, has been subscribed 39.92 times. The public issue was subscribed 166.58 times in the retail category, 3.10 times in qualified institutional buyers segment and 31.59 times in the non-institutional investors category.
The shares of Nureca, which owns the Dr Trust brand, were offered in the price band of Rs 396-400 per share. The shares are likely to be listed on the BSE Sensex and NSE on February 26, 2021.
Ahead of the share sale, on Friday, Nureca had allotted 11,13,750 shares to two anchor investors at the higher end of the price band, at Rs 400 per share. The company thus raised Rs 44.55 crore.
Nureca will utilise the share proceeds of the public offer to fund its incremental working capital requirements and for general corporate purposes.
Incorporated in November 2016, Nureca is in the business of home healthcare and wellness products. It sells its products on its own website as well as online channel partners such as e-commerce players, distributors and retailers.
ITI Capital Ltd is the sole book running lead manager and Link Intime India Private is the registrar to the issue.